CSPC Pharmaceutical Group Limited Share Price
Stocks
1093
HK1093012172
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.350 HKD | +1.52% |
|
+3.67% | -12.81% |
| 11/06 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 11/06 | Alphamab Says Phase 3 Study of Breast Cancer Drug Meets Primary Endpoint | MT |
| Market Cap | 8.4TCr 1.07TCr 926.24Cr 853.53Cr 798.95Cr 1.5TCr 1,01900Cr 1.52TCr 10TCr 3.93TCr 50TCr 4.02TCr 3.94TCr 1,71800Cr | P/E Ratio 2026 * |
10.3x | P/E Ratio 2027 * | 11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 7.3TCr 931.42Cr 804.47Cr 741.32Cr 693.91Cr 1.3TCr 89TCr 1.32TCr 8.75TCr 3.41TCr 43TCr 3.5TCr 3.42TCr 1,49200Cr | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 2.01x |
| Free-Float |
67.53% | Yield 2026 * |
4.96% | Yield 2027 * | 5.05% |
| 1 day | +1.52% | ||
| 1 week | +3.67% | ||
| Current month | -2.00% | ||
| 1 month | -5.53% | ||
| 3 months | -18.60% | ||
| 6 months | -2.13% | ||
| Current year | -12.81% |
| 1 week | 6.92 |  | 7.57 |
| 1 month | 6.64 | | 7.88 |
| Current year | 6.64 | | 10.96 |
| 1 year | 6.64 | | 11.63 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 12.42 |
| 10 years | 3.37 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Cai
CEO | Chief Executive Officer | 46 | 19/12/2025 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 19/12/2025 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 01/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 26/08/2011 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 20/01/2012 |
Bo Wang
BRD | Director/Board Member | 66 | 21/12/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/05 | Other | Chairman | 94,02,000 | 0.0816% | ||
| 28/05 | Other | Chairman | 4,00,00,000 | 0.3471% | ||
| 23/12 | Other | Chairman | 67,06,000 | 0.0582% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | +3.67% | -16.00% | +8.89% | 1.06TCr | |
| -1.37% | +0.14% | +38.28% | +153.06% | 1,01000Cr | |
| -1.56% | +3.48% | +53.32% | +49.09% | 58TCr | |
| -2.45% | +0.22% | +19.18% | +67.17% | 40TCr | |
| -0.40% | 0.00% | +21.28% | +19.14% | 33TCr | |
| -1.18% | +3.46% | +25.97% | +34.34% | 28TCr | |
| -1.75% | -3.38% | +23.22% | +14.07% | 28TCr | |
| -0.74% | +5.72% | -42.27% | -47.93% | 20TCr | |
| -0.60% | +1.61% | +20.32% | +59.80% | 19TCr | |
| -0.52% | -2.76% | +14.19% | +61.12% | 16TCr | |
| Average | -0.88% | +0.76% | +15.75% | +41.87% | 34.39TCr | |
| Weighted average by Cap. | -1.20% | +1.03% | +27.84% | +70.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.55TCr 453.41Cr 391.61Cr 360.87Cr 337.79Cr 633.04Cr 43TCr 642.84Cr 4.26TCr 1.66TCr 21TCr 1.7TCr 1.67TCr 73TCr | 3.51TCr 448.35Cr 387.24Cr 356.84Cr 334.02Cr 625.98Cr 43TCr 635.67Cr 4.21TCr 1.64TCr 21TCr 1.68TCr 1.65TCr 72TCr |
| Net income | 772.78Cr 99Cr 85Cr 78Cr 73Cr 137.69Cr 9.37TCr 139.82Cr 926.81Cr 361.35Cr 4.56TCr 370.12Cr 362.24Cr 16TCr | 689.37Cr 88Cr 76Cr 70Cr 66Cr 122.83Cr 8.36TCr 124.73Cr 826.78Cr 322.35Cr 4.07TCr 330.17Cr 323.15Cr 14TCr |
| Net Debt | -1.1TCr -140.99Cr -121.77Cr -112.21Cr -105.04Cr -196.84Cr -13TCr -199.89Cr -1.32TCr -516.59Cr -6.52TCr -529.12Cr -517.86Cr -23TCr | -1.33TCr -170.15Cr -146.96Cr -135.42Cr -126.76Cr -237.56Cr -16TCr -241.24Cr -1.6TCr -623.44Cr -7.87TCr -638.57Cr -624.97Cr -27TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 7.350 $ | +1.52% | 7,67,98,293 |
| 12/26/12 | 7.240 $ | +0.42% | 9,16,47,920 |
| 11/26/11 | 7.210 $ | -0.69% | 7,61,31,040 |
| 10/26/10 | 7.260 $ | +3.71% | 10,66,51,600 |
| 09/26/09 | 7.000 $ | -1.27% | 10,08,03,763 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Select your edition
All financial news and data tailored to specific country editions
